Clinical application of gonadotropin-releasing hormone analogs in children and adolescents.
10.3345/kjp.2010.53.3.294
- Author:
Ho Seong KIM
1
Author Information
1. Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea. kimho@yuhs.ac
- Publication Type:Review
- Keywords:
Central precocious puberty;
Gonadotropin-releasing hormone analogs;
Child;
Adolescent
- MeSH:
Adolescent;
Child;
Gonadotropin-Releasing Hormone;
Humans;
Incidence;
Korea;
Piperazines;
Puberty, Precocious;
Uncertainty
- From:Korean Journal of Pediatrics
2010;53(3):294-299
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although the increasing incidence of central precocious puberty (CPP) in Korea has recently raised public concerns about health and growth problems, there are many areas of uncertainty regarding the pathogenesis, diagnosis, and management of CPP. In this paper, we review the definition of precocity, the assessment of CPP, and the hormonal abnormalities that support the diagnosis. In addition, we review the practical guidelines regarding the clinical use of gonadotropin-releasing hormone analogs in children with CPP. Indications for treatment, determination of dosage, monitoring during treatment, and discontinuation of therapy are discussed.
